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The intent of this study was to determine whether nutritional supplements [protein (0.4 g·kg−1) vs. carbohy-
drate (0.4 g·kg−1) vs. placebo] would affect muscle recovery differently after eccentric exercise-induced mus-
cle soreness in untrained healthy young men (n = 21) aged 20–28 years. During this double-blind randomized
block study design, each subject completed three, 3-day trials (separated by ≥ 2 weeks), identical except for
treatment, with each subject serving as his own control. Trials began with a bout of right-leg eccentric exer-
cise (Biodex), followed directly by treatment. At 0 (baseline), 24 and 48 hours, data were collected: creatine
phosphokinase from pre-exercise blood samples, subjective muscle soreness questions, and strength tests
(power, torque, work). ANOVA indicated that exercise caused mild muscle damage, as evidenced by an over-
all day effect (p ≤ 0.0001) for muscle soreness, with the lowest median values (0–10 scale) on day 1 (0.7),
increasing (p ≤ 0.0001) on day 2 (3.2), and remaining elevated on day 3 (3.4). We also noted an overall day
effect (p ≤ 0.0001) for creatine phosphokinase, with the lowest median values on day 1 (136 U·L−1), increas-
ing (p ≤ 0.0001) on day 2 (235 U·L−1), and remaining elevated on day 3 (189 U·L−1). ANOVA revealed no sig-
nificant treatment effect on indicators of soreness or damage during recovery. Our results indicated that
protein or carbohydrate supplement after exercise that caused mild muscle damage did not facilitate muscle
recovery in adequately nourished, healthy young men. [ J Exerc Sci Fit • Vol 8 • No 2 • 89–96 • 2010]
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Introduction
Unaccustomed exercise typically causes muscle sore-
ness, which usually begins within 24 hours and peaks
within 48 hours after exercise. Eccentric exercise, which
occurs when a skeletal muscle lengthens as it produces
force, provides a common exercise mode to induce mus-
cle damage. Common responses to exercise-induced
muscle damage include increased muscle soreness
(Newham et al. 1983b), decreased peak torque, de-
creased power output, decreased range of motion
(Chapman et al. 2006; Paschalis et al. 2005b; Vincent &
Vincent 1997), increased inflammatory response
(Stupka et al. 2000), and increased creatine phospho-
kinase (CPK) (Nosaka et al. 2006; Paschalis et al. 2005b;
Byrnes et al. 1985). Effective eccentric exercises include
running downhill (Newham et al. 1986), stepping down
(Newham et al. 1983a), and action of the elbow flexors
(Chapman et al. 2006) or knee extensors (Paschalis et al.
2005b) on a dynamometer. The extent of muscle dam-
age, however, depends on the sex (Pincivero et al.
2003; Stupka et al. 2000), training status (Vincent &
Vincent 1997), and/or nutritional status of the individual.
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During exercise, amino acids are used to build and
repair tissue as well as to supply energy, whereas carbo-
hydrate is the primary energy source for muscle contrac-
tion. In the event that amino acids and/or carbohydrate
may be limiting substrates during the course of exer-
cise, optimal muscle protein synthesis and turnover, as
well as muscle recovery, may be impeded (Bohe et al.
2003). Hence, nutrition supplements before or after ec-
centric exercise may significantly impact muscle damage
and muscle recovery; specifically, a protein supplement
has considerable potential to decrease muscle damage
and soreness (Ohtani et al. 2006; Sugita et al. 2003). In
previous studies (Tipton & Wolfe 2001, 1998), increases
in whole body and muscle protein accretion were noted
with ingestion of a protein supplement immediately fol-
lowing exercise. Studies reported that amino acid sup-
plements given after exercise led to more rapid recovery
from muscle fatigue, decreased plasma CPK activity,
decreased muscle soreness, and lessened exercise-
induced proteolysis (Ohtani et al. 2006; Flakoll et al.
2004; Nissen et al. 1996). Further research (Levenhagen
et al. 2001) suggested that post-exercise protein inges-
tion was most beneficial to muscle protein accretion
when consumed immediately after exercise versus
several hours later. Researchers (Zehnder et al. 2004;
Sherman et al. 1983) have also investigated whether
carbohydrate supplements decrease muscle soreness
because of increased energy availability or muscle gly-
cogen repletion. However, most researchers found that
carbohydrate intake did not affect CPK activity (Close
et al. 2005), muscle soreness (Close et al. 2005; Nelson
et al. 2004), and/or muscle strength (Nelson et al. 2004).
Nevertheless, we thought it was important to compare
a protein supplement with an energy-equivalent car-
bohydrate supplement in apparently well-nourished
healthy men.
The intent of this study was to determine whether
nutritional supplements (protein vs. carbohydrate vs.
placebo) would affect muscle recovery differently after
exercise-induced muscle soreness in untrained healthy
young men. Our hypothesis was that a protein supple-
ment would promote more rapid and greater muscle
recovery after a single bout of exercise-induced muscle
soreness compared with carbohydrate or placebo.
Methods
This double-blind crossover study was designed to com-
pare the effects of protein, carbohydrate and placebo
beverage supplements on muscle recovery using an
indirect marker of muscle damage (CPK) and indepen-
dent markers of muscle function (muscle soreness ques-
tionnaire, muscle strength test). Each subject served as
his own control, and thus completed the identical pro-
tocol three times, consuming one of three supplements
each time. The supplements were administered in ran-
dom order, thus preventing a trial sequence effect. The
supplements were composed of: (1) protein [whey pro-
tein (0.4 g·kg−1 body weight) with cherry flavoring (Syn-
trax; SIO3 Inc., Cape Girardeau, MO, USA)] dissolved in
240 mL of water; or (2) carbohydrate [sugar (0.4 g·
kg−1 body weight) and cherry flavoring (Kraft Foods
Global, Inc., Glenview, IL, USA)] dissolved in 240 mL of
water; or (3) placebo [artificial sweetener (0.0485g·kg−1
body weight; McNeil Nutritionals, LLC, Ft. Washington,
PA, USA) and cherry flavoring (Kraft Foods Global, Inc.)]
dissolved in 240 mL of water. Protein and carbohydrate
treatments were isocaloric. Each subject served as his
own control.
Subject criteria and selection
The study design, purpose, and potential risks were ex-
plained to each potential subject, with an opportunity
to ask questions. Prior to screening, each subject signed
an informed consent document. The Human Subjects
Institutional Review Board at Iowa State University ap-
proved the study (IRB ID#05-341). All portions of the
study were carried out in the Fitness and Metabolism
Unit (FMU) of the Nutrition and Wellness Research
Center on the Iowa State University campus. Prior to en-
rolment in the study, each volunteer was screened to
determine eligibility, and measurements were recorded
for height, weight, blood pressure and heart rate. Height
and weight were used to calculate the body mass index
(BMI) for each subject. Volunteers were required to be
non-smokers, untrained, 18–28-year-old males, with a
BMI in the range of 18.0–29.9 kg·(m2)−1. To further
determine eligibility and screen for past or current health
problems, each potential subject completed a medical
history and a physical activity questionnaire. Phleboto-
mists collected blood samples by venepuncture from
fasted (10 hours) participants between 6:00 a.m. and
8:30 a.m. Each participant had an initial blood draw
for whole blood and serum samples, respectively, ana-
lyzed for a complete blood count with differential and
a general chemistry panel (ChemScreen) by a certified
clinical laboratory (Laboratory Corporation of America,
Kansas City, MO, USA). We excluded volunteers with
evidence of hypertension, liver disease, kidney dis-
ease, diabetes, asthma, and/or abnormal blood values.
We included subjects who had maintained a relatively
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constant degree of physical activity and excluded those
who had recently increased their level of resistance train-
ing prior to participating in this study. Subjects were
required to refrain from vitamin/mineral supplement
and medication use during the study. We enrolled vol-
unteers in the study who met all the inclusion criteria
and none of the exclusion criteria.
Protocol
We chose a protocol similar to that used in previously
published studies (Paschalis et al. 2005b; Babul et al.
2003; Stupka et al. 2001). Bioelectrical impedance analy-
sis was used to assess body composition (Quantum
Bioelectrical Body Composition Analyzer; RJL Systems,
Clinton Township, MI, USA), with three measurements
recorded and averaged for each subject. During screen-
ing, each volunteer participated in an exercise test to
measure leg flexion/extension muscle strength on the
dynamometer (Biodex System 3 Isokinetic Dyna-
mometer; Biodex Medical Systems, Shirley, NY, USA),
and participated in a short training session that ex-
plained the future exercise protocol. Muscle strength
indicators recorded during this baseline test and all sub-
sequent exercise tests included: extension peak torque,
extension maximum repetition total work, extension
average power, extension average peak torque, flexion
peak torque, flexion maximum repetition total work, flex-
ion average power, and flexion average peak torque.
Subjects were instructed to maintain their normal
diets before and during the study, but they were in-
structed to not exceed two alcoholic beverages per
day, beginning 3 days before and lasting until the com-
pletion of the trial. Also, subjects were instructed to re-
frain from any unaccustomed exercise beginning 1 week
before and lasting until the completion of the trial.
Each participant completed three, 3-day trial periods.
Beginning 3 days before the first visit to the FMU, each
subject kept a written 24-hour dietary intake record.
This record continued until the first day of the trial
(time = 0 hours), and thus the record did not include
the protein or carbohydrate supplement administered
during the trial. Each subject also began recording his
24-hour physical activity record the day prior to the
first day of the trial. This record continued until the
end of each trial.
Each trial began with the fasted subjects arriving at
the FMU in the early morning (0 hours). Researchers
measured height, weight, blood pressure and heart
rate, and a phlebotomist drew blood by venepuncture.
Each subject recorded his initial muscle soreness, per-
formed a short muscle strength test on the dynamometer
identical to the screening test, and completed a level
of exertion evaluation. The subjects self-reported their
soreness using a continuous-range evaluation scale
(0–10, with 0 representing “not at all sore” and 10 repre-
senting “extremely sore”) (Chapman et al. 2006; Nosaka
et al. 2006). Perceived level of exertion was assessed
using a scale from 0 cm to 10 cm (with 0 representing
“no exertion” and 10 representing “maximum exer-
tion”). The purpose of this evaluation was to encourage
subjects to exert maximal effort and for researchers to
compare exertion levels between trials.
Each subject performed the eccentric exercise proto-
col intended to induce muscle damage, which consisted
of 10 sets of 10 repetitions of eccentric knee extensions
at 60 deg·s−1 on a Biodex dynamometer. The range of
motion was set from 90° to 180° and intensity was
set relative to each subject’s initial maximum strength
test (concentric single repetition maximum). Subjects
were encouraged to perform maximal voluntary effort
through verbal encouragement, and they were asked
to achieve a designated target as shown on the Biodex
screen. A 1-minute break occurred between each inter-
val to enable subjects to resist the torque of the Biodex;
the entire protocol lasted about 15 minutes. After the
first and last exercise intervals, each subject completed
an evaluation of his level of exertion. Immediately fol-
lowing the exercise protocol, each subject drank the
protein or carbohydrate or placebo beverage. He then
completed another evaluation of his muscle soreness
and provided another blood sample. Thirty minutes after
exercising, each subject had his blood pressure and heart
rate taken. He was then allowed to leave the FMU, but
was asked to refrain from consuming any food until at
least 45 minutes after the completion of exercise. This
was to ensure comparability across subjects and to min-
imize the influence of potentially confounding factors.
Water was provided ad libitum throughout the protocol.
Subjects returned to the FMU in a fasted state the
following 2 days (24 and 48 hours), at approximately
the same assigned time as the first day. Preliminary
measurements of weight, blood pressure and heart rate
were recorded, and a blood sample was taken. Each
subject completed a muscle strength test, an evalua-
tion of level of exertion, and an adverse events ques-
tionnaire. Muscle soreness evaluations for the right leg
were completed before and after the strength test. At
least 2 weeks after the first trial, each subject returned
and repeated identical protocol, except that a different
treatment beverage was consumed. At least 2 weeks
later, each subject again returned, and ingested the
third beverage option.
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Analysis of dietary and physical activity records
An important goal of the study was to maintain similar
circumstances throughout all trials to minimize poten-
tial confounding from various extraneous factors. Thus,
each subject was asked to maintain a similar dietary
intake and physical activity level for 3 days prior to
each trial, as well as identical eccentric exertion during
all three trials. All 24-hour diet records were analyzed
using Nutritionist Pro (Axxya Systems, Stafford, TX,
USA) nutrition analysis software. All 24-hour physical
activity records were analyzed by quantifying subjects’
daily activities (metabolic equivalents) as rest, light
activity, moderate activity, or heavy activity. These cat-
egory distinctions were based on standard published
lists of various activities (Ainsworth et al. 1993).
Analysis of blood samples
We separated plasma from whole blood (centrifuged at
room temperature for 10 minutes at 1,500g) and stored
aliquots at −80°C until analyses. We determined plasma
CPK activity in duplicate using a Creatine Kinase
Reagent Set (Pointe Scientific, Inc., Canton, MI, USA),
according to the manufacturer’s instructions. The ab-
sorbance (measured at 340 nm) of the samples was
determined on a Beckman spectrophotometer (Beckman
Coulter, Inc., Fullerton, CA, USA) and compared to stan-
dards provided by the company. The spectrophotometer
measured the rate of NADH formation, directly pro-
portional to serum CPK activity (mediating conversion
of creatinine phosphate to creatine).
Statistical analysis
Statistical analyses were performed using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA), with results consid-
ered statistically significant at p ≤ 0.05. Descriptive sta-
tistics included means (±standard deviation) for normally
distributed data (height, weight, level of exertion, dietary
intake, physical activity levels, and muscle strength
values) and medians for data that were not normally
distributed (CPK and muscle soreness). To determine
whether day (0, 24 or 48 hours), trial number or treat-
ment type exerted an effect on CPK or muscle sore-
ness, ANOVA was performed. We used a mixed model,
with fixed effects for day, trial and treatment, and
incorporated a random effect for subject.
Results
Initial subject characteristics for the 21 healthy young
males in their twenties are reported in Table 1. Based
on BMI, none of the subjects were obese. At baseline,
ANOVA revealed no statistical differences in subject
characteristics/activities among the three treatment
groups (protein, carbohydrate, placebo) (Table 2). The
main indices of muscle damage after the eccentric exer-
cise protocol were CPK (U·L−1) and subjective muscle
soreness evaluations (0–10-cm scale), although we also
assessed exercise measures of strength from the Biodex.
It was clear that the eccentric exercise protocol caused
the intended muscle damage (Figures 1 and 2). ANOVA
for overall day effect revealed significant differences for
CPK (p ≤ 0.0001) and muscle soreness (p ≤ 0.0001), as
well as 6 of 8 muscle strength tests (p value ranged from
0.007 to 0.034), with smaller values for muscle soreness
on day 1 compared with day 2 or day 3. Clearly, the ec-
centric exercise effectively achieved muscle damage.
In examining the overall trial effect, we noted several
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Table 1. Characteristics of the 21 subjects at baseline*
Age (yr) 23 ± 2 (20–28)
Weight (kg) 79.2 ± 10.1 (63.7–98.2)
Height (cm) 179.6 ± 5.4 (170.1–191.2)
Body mass index [kg·(m2)−1] 24.6 ± 3.0 (19.8–29.9)
Lean body mass† (kg) 63.7 ± 5.3 (53.9–73.4)
Lean body mass (%) 80.1 ± 4.0 (72.0–88.5)
Fat mass† (kg) 16.2 ± 5.0 (8.4–27.1)
Fat mass (%) 19.9 ± 4.0 (11.5–28.0)
*Data presented as mean± standard deviation (range); †assessed using
bioelectrical impedance analysis.
Table 2. Dietary intake of the 21 subjects at baseline according to treatment*†
Treatment group Comparison among 
Potential confounding factors
Placebo Protein Carbohydrate groups, p
‡
Energy (kJ·d−1) 7,934 ± 1,800 8,093 ± 1,775 8,273 ± 2,403 0.86
Protein (g·d−1) 78 ± 17 75 ± 17 83 ± 21 0.41
Carbohydrate (g·d−1) 236 ± 66 244 ± 56 248 ± 92 0.87
Fat (g·d−1) 73 ± 26 74 ± 36 81 ± 27 0.66
*Data presented as mean ± standard deviation; †dietary intake does not include protein or carbohydrate supplement intake; ‡no significant
differences (ANOVA) in energy or macronutrient intake among treatment groups.
significant differences among trials. ANOVA for overall
trial effect showed significant differences for muscle
soreness (p≤0.0001) and 6 of 8 exercise muscle strength
tests (p value ranged from ≤ 0.0001 to 0.017). Specifi-
cally, greater muscle damage occurred during trial 1 than
during trial 2 or 3, as evidenced by statistically signifi-
cant differences in muscle soreness values between tri-
als 1 and 2 (p ≤ 0.0001) and between trials 2 and 3 (p =
0.0002), as well as greater CPK values (p = 0.039) and
several muscle strength indices in trial 2 compared with
trial 1. We analyzed CPK activity and muscle soreness
evaluation by treatment type, as depicted graphically
(Figures 1 and 2). However, examining the overall treat-
ment effect, we documented no significant difference as
indicated by either CPK or muscle soreness values. Thus,
the eccentric exercise protocol produced significant mus-
cle damage with a documented trial effect, but treatment
type had no effect on muscle soreness or recovery.
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Fig. 1 Serum creatine phosphokinase (CPK) activity according
to treatment. *There was no significant difference in CPK
activity (ANOVA) among treatment groups.
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Fig. 2 Muscle soreness evaluation (0–10-cm scale) according
to treatment. *There was no significant difference in muscle
soreness (ANOVA) among treatment groups.
Discussion
Contrary to other studies (Ohtani et al. 2006; Sugita et al.
2003), the results of this study indicated no significant
effect of treatment on muscle damage, soreness or
recovery after moderate eccentric exercise (Figures 1
and 2). However, similar to previous studies (Chapman
et al. 2006; Paschalis et al. 2005a; Vincent & Vincent
1997; Newham et al. 1983a, the eccentric exercise pro-
tocol successfully induced muscle damage, as evidenced
by increased CPK activity and perceived muscle sore-
ness values from day 1, above that of sequential trials
on days 2 and 3. Also, not surprisingly and similar to
other studies (Stupka et al. 2001; Byrnes et al. 1985),
we documented a trial effect, with significantly greater
muscle damage during and after trial 1 compared with
trial 2 or 3. This protective effect due to repeated exer-
cise exposure is well documented, and undoubtedly, the
2-week minimum recovery time we required between
trials was not sufficiently long to overcome the protec-
tive effect. Perhaps as a control, we might have used the
non-dominant leg.
Although several studies (Ohtani et al. 2006; Flakoll
et al. 2004; Sugita et al. 2003; Wojcik et al. 2001) indi-
cated that protein and/or carbohydrate supplements
after eccentric exercise decreased muscle damage com-
pared with placebo, some authors (Williams 1999;
Kreider et al. 1993) remain skeptical that protein and/or
carbohydrate supplements cause increased muscle re-
covery. Evidence for a lack of effect on muscle recovery
has been demonstrated recently in female participants
who underwent exercise-induced muscle injury and
then consumed a carbohydrate or carbohydrate/protein
beverage immediately after eccentric exercise (Green
et al. 2008). Thus, our results concur with this study in
females.
A few possible factors may explain why our data
did not indicate significantly decreased muscle dam-
age after protein and/or carbohydrate supplement
intake. Perhaps the main reason we did not document
a treatment effect was because our exercise protocol
induced mild-to-moderate muscle damage. Other
studies using alternative eccentric exercise protocols
created more severe muscle damage, indicated by
CPK activity as high as 1,500 U·L−1 from downhill walk-
ing (Newham et al. 1986) or as high as 34,500 U·L−1
from eccentric stepping (Newham et al. 1983a). Our
aim was to determine whether a protein supplement
would increase muscle recovery subsequent to a less
extreme degree of muscle damage, to simulate a more
realistic and applicable situation. Thus, we chose to use
a less damage-producing protocol similar to published
studies (Paschalis et al. 2005b; Babul et al. 2003;
Stupka et al. 2001).
Another possible explanation for the lack of treat-
ment effect may have been the small dose of protein
(0.4 g protein·kg−1 body mass) provided to the appar-
ently well-nourished subjects in this study. Although
their reported energy [∼7,934 kJ·d−1 (1,896 kcal)] intake
(based on three, 24-hour diet records) was low, it is un-
likely that our participants’ diets were lacking in either
energy or protein (78–83 g·d−1), since they did not lose
weight during the study. These values were likely an un-
derestimate of energy intake, given that study partici-
pants typically underreport dietary intake (Jonnalagadda
et al. 2000). One would expect that in well-nourished
individuals, the extracellular pool of amino acids would
not be particularly limiting, except perhaps after a long-
term fast (Bohe et al. 2003). Hence, a relatively small
amount of supplemental protein may not be sufficient
to exert an effect on extracellular amino acid concentra-
tions and thus influence intracellular protein synthesis
subsequent to moderate muscle damage. The dose ad-
ministered in research studies (Williams et al. 2003;
Wojcik et al. 2001) varies greatly, but it is commonly
∼1.0 g protein·kg−1 body mass. However, studies often
administer much larger doses. One study (Nosaka et al.
2006) compared the effect of ingesting various doses
of a protein supplement (with one dose being 3.6 g) on
exercise-induced muscle damage. Before and after en-
durance exercise using the elbow flexors, subjects in-
gested a total of either two (7.2 g) or 10 (36 g) doses of
protein supplement. The subjects who consumed only
two protein doses versus placebo reported no significant
difference in CPK activity or muscle soreness, but those
who consumed 10 protein doses versus placebo showed
significantly lower CPK activity and muscle soreness.
Clearly, the greater but not lesser amount of protein in
supplement form exerted a significant effect on muscle
recovery after exercise. Our study was performed before
the Nosaka et al. (2006) study was published.
Our study had several limitations in that the partici-
pants were self-selected, 20–28-year-old, well-nourished,
healthy male volunteers. Hence, the results are not appli-
cable to the male population as a whole, and conclu-
sions from the data cannot be generalized to females.
Another limitation was that the subjects were free-living
men, and thus we did not control the subjects’ physi-
cal activity or dietary intake. Although subjects were
instructed to refrain from physical activity for 1 week
before each trial, their actual physical activity was 
not prescribed or quantified. Thus, their usual physical
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activity may have had an undeterminable effect on mus-
cle soreness and CPK activity. Although each subject was
instructed to repeat his 3-day recorded dietary intake
from the first trial during the second and third trials, this
did not necessarily occur in practice in the majority of
the subjects. Also, the exercise bouts were performed on
a Biodex machine, which uses a person’s own resis-
tance to determine his level of power output. Subjects
were strongly encouraged to work as hard as they were
able and we provided visual targets as goals on the
Biodex screen, but the work performed from subject
to subject undoubtedly varied. However, because each
subject served as his own control, this should not have
confounded the overall results, as long as each subject
performed similarly from trial to trial. Indeed, from the
researchers’ perspective, subjects performed similarly
from trial to trial. In addition, we evaluated a relatively
small number (n = 21) of subjects, although similar stud-
ies (Paschalis et al. 2005a; Nelson et al. 2004) indicated
a response to treatment, with subject numbers ranging
from 5 to 20. However, a trial with a greater number of
subjects would provide greater statistical power for de-
tecting small changes, which may not have been de-
tectable in our study because of inherent interindividual
variability and relatively small treatment doses. Never-
theless, this trial mimicked real-life situations, which is
one of this study’s strengths.
In conclusion, a protein or carbohydrate supplement
consumed after moderate eccentric exercise did not
significantly affect muscle damage or recovery, likely
because muscle damage was mild and the supplement
dose was relatively low (0.4 g·kg−1 body weight). Fur-
ther research with subjects who are marginally nourished
or with older subjects is warranted to determine whether
larger doses of supplement may promote recovery in the
face of greater exercise-induced muscle damage.
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